Thomas Delea

Background

About Thomas Delea

Tom is a Senior Project Advisor at Avalere Health. Tom started his career in HEOR at PAI in the '90s, where he worked for over 20 years eventually becoming a Senior Consultant. In 2005, he and his partner's purchased PAI from the legacy ownership. For five plus years Tom and his partners rebuilt the consulting business and created a new business in Hero3, a novel web based software platform for economic modeling. In January 2022, they sold the two businesses to Fishawack Health, a leading global commercialization partner for the biopharmaceutical, medical technology, and wellness industries, adding HEOR to Fishawack's existing market access, medical communication and marketing capabilities. In October 2023, Fishawack Health became Avalere Health. Tom is an expert in economic evaluations of health technologies, analyses of real-world data, and evidence synthesis. During his more than 30 years of experience in HEOR, Tom has directed hundreds of client engagements including RWE studies, economic evaluations to support manufacturer submissions to reimbursement authorities, ITCs, NMAs, meta-regressions, population-adjusted indirect comparisons, and development of HEOR plans and strategies. He has over 60 publications in scientific journals and hundreds of posters and presentations at scientific meetings. He is an expert in the development and estimation of models for evaluating the cost-effectiveness of novel oncology therapies and has directed the development on numerous such models used in successful manufacturer submissions to reimbursement authorities such as pCODR and NICE. He has given numerous courses on a variety of subjects relating to health economics and outcomes research, and has reviewed for numerous medical and health economics journals. He received his B.A. in Economics and Mathematics from Colby College, Waterville, Maine and his Masters of Science in Industrial Administration (MSIA) from the Carnegie Mellon University, Pittsburgh, Pennsylvania.